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Abstract  
Over the past 15 years, the multidisciplinary team management of many medical conditions especially cancers has increasingly taken a prominent 
role in patient management in many hospitals and medical centres in the developed countries. In the United Kingdom, it began to gain prominence 
following the Calman-Heine report in 1995 which suggested that each Cancer Unit in a hospital should have in place arrangements for non-surgical 
oncological input into services, with a role for a non-surgical oncologist. The report further suggested that a lead clinician with a well established 
interest in cancer care should be appointed to organise and coordinate the whole range of cancer services provided within the Cancer Unit. Many 
people have argued that the multidisciplinary team management of patients has resulted in better care and improved survival. However, there are 
barriers  to  the  optimal  effectiveness  of  the  multidisciplinary  team.  This  paper  aims  to  review  various  studies  on  the  effectiveness  of  the 
multidisciplinary team in the management of cancer patients and also discuss some of the barriers to the multidisciplinary team.  
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Introduction 
 
A multidisciplinary team (MDT) is a group of health care members in different disciplines, each providing specific services to the patient with the 
aim of ensuring that the patient receives optimum care and support. The importance of a multidisciplinary team was particularly highlighted by the 
1995 Calman-Heine report which suggests in its recommendation that each Cancer Unit in a hospital should have in place arrangements for non-
surgical oncological input into services, with a role for a non-surgical oncologist and that a lead clinician with a well established interest in cancer 
care should be appointed to organise and coordinate the whole range of cancer services provided within the Cancer Unit [1]. The report went 
further to recommend that other services such as physiotherapy, nursing, dietetics, speech therapy, chaplaincy and social services should all be 
easily available [1]. Ever since this report was published, multidisciplinary team for cancer patients is now well established in many hospitals across 
England and Wales [2-7]. This paper is aimed at discussing the effectiveness of multidisciplinary team management of cancer patients.  
  
The need for multidisciplinary care  
  
Previous management of cancer patients before the idea of MDT management was conceived involved the referral of patients from one clinician to 
another at various stages of diagnosis and treatment without an integrated approach, which can be an overwhelming and confusing experience for 
a patient. This resulted in uncoordinated patient care and low patient satisfaction with services.  
  
South East Wales  
  
The National Health Service Wales (NHS Wales) states that a typical MDT should include [8]: a lead clinician, a team co-ordinator/secretary, a 
surgeon, an oncologist, a radiologist, a histo-pathologist, a clinical nurse specialist and specialist palliative care nurse.  
  
  
Methods 
 
Thorough search of the English literature was conducted using search engines such as PubMed, Google and Medline with words that include: 
“multidisciplinary  team”,  “effectiveness  of  MDM”  and  “multidisciplinary  team  management  of  cancer”.  Studies  that  evaluated  team  working 
effectiveness  in  the  management  of  patients  with  cancer  were  included.  Specific  data  such  as  number  of  patients  involved  in  the  studies, 
methodology of the studies and the outcome of the studies were noted.  
  
  
Results 
 
A number of studies have been carried out to evaluate the effectiveness of MDT management of cancer patients. In a cohort study in the United 
States, 269 patients who were diagnosed with urological cancer outside a particular large health institution and then presented to the large health 
institution for diagnostic or treatment consideration were studied [9]. The cohort included patients with the diagnosis of cancer of the prostate 
(34%), bladder (23%), kidney (35%) and testicle (5%). The researchers state that all the cases were reviewed and discussed at a cancer board in 
the presence of all members of the different subspecialties. Following the MDT meeting, changes in diagnosis were made in 23% of the bladder 
cases and 17% of renal cases. Also, changes in treatment were made in 44% of the bladder cancer cases, 36% of renal cases and 29% of 
testicular cancer cases [9]. This result suggests that a multidisciplinary team approach affects the diagnostic and management decisions in a 
considerable number of patients with a newly diagnosed urologic malignancy.  
  
In another study aimed at evaluating the effect of a colorectal multidisciplinary team in the United Kingdom, 310 patients were studied following 
the establishment of a multidisciplinary cancer team in a hospital [10]. The pre-MDT cohort over a 5-year period prior to the establishment of a 
MDT  was  176  and  the  post-MDT  cohort  was  134  [10].  The  study  shows  that  a  significant  number  of  patients  were  prescribed  adjuvant 
chemotherapy in the post-MDT cohort and three-year survival for Duke C patients was 58% in the pre-MDT group, compared to 66% in the post –
MDT group [10]. This study suggests that the establishment of an MDT has resulted in a significant increase in the number of patients undergoing 
adjuvant chemotherapy which resulted in an increase in the 3-year survival of Duke C patients.  
  
In  a  hospital  in  Glasgow,  243  patients  with  inoperable  non-small-cell  lung  cancer  were  examined  before  and  after  the  introduction  of  a 
multidisciplinary team. Of the 243, 117 were studied before and 126 were studied after the inception of an MDT and there were no differences in 
age, sex and extent of deprivation between the two cohorts [11]. Three years after the introduction of a MDT, 23% received chemotherapy, 
compared to only 7% in the year prior to the inception of MDT while 44% of post MDT patients received palliative care only compared to 58% of 
pre-MDT patients. In addition, median survival post-MDT was 6.6 months, compared to 3.2 months pre-MDT [11]. This study suggests that MDT 
management of cancer patients not only results in the change of treatment of patients, but also significantly increase survival. Several other 
studies have also suggested that MDT management improves patients’ quality of life and survival and is vital for second opinions [12,13].  
  
Fader and colleagues also evaluated the cost effectiveness of multidisciplinary care in Michigan, United States of America [14]. They studied the 
cost  effectiveness  of  the  Multidisciplinary  Melanoma  Clinic  (MDMC)  compared  to  the  traditional  community-based  treatment.  In  the  study,  a 
consecutive sample of 104 patients with local disease who were treated in the Michigan community was compared with 104 blindly selected 
subjects treated at the MDMC during a similar time period. The authors concluded that multidisciplinary care would save $1600 (£969) per patient 
when compared with the group treated in the community.  
  
In another study by Gabel and colleagues, they evaluated patients’ satisfaction in the management of newly diagnosed breast cancer patients 
before and after the establishment of a multidisciplinary breast cancer clinic (MDBCC) [15]. 166 patients who were referred in the traditional 
consultation manner were evaluated in the control group during the year prior to the establishment of MDBCC. They were compared with the first Page number not for citation purposes  3 
177 patients seen during the first year of the clinic’s operation. The authors reported that MDBCC increased patient satisfaction by encouraging 
input of patients´ families and friends and by helping patients make treatment decisions (P < 0.001) [15]. They also found that the time between 
diagnosis and the initiation of treatment was considerably reduced (42.2 days vs. 29.6 days; P < 0.0008).  
  
Only very few publications have suggested that the multidisciplinary team management of cancer patients is ineffective. Acher et al studied 124 
cases  of  urological  cancers  discussed  in  10  MDT  meetings  over  a  six  month  period  and  discovered  that  only  two  cases  had  their  clinical 
management changed as a result of the meeting, while four changes were made due to histological reports and 1 to radiology, none of which had 
an effect on clinical management [16]. Although the result of this study may not have shown a statistical significance, the fact that two patients 
had their clinical management changed is of clinical significance because this could have an effect on the morbidity and mortality of the patients 
who had their clinical management changed.  
  
Team’s perspective  
  
It has been shown that many MDT members believe that MDT meetings are very effective. In a study of 253 Colorectal Surgeons and Colorectal 
Clinical Nurse Specialists by Sharma and associates, it was revealed that 96.5% of respondents believed that MDTs improved the overall quality of 
care of colorectal cancer patients and 73% thought that MDTs were cost effective [17].  
  
Barriers to Multidisciplinary Teamwork  
  
Although it is well known that the multidisciplinary team management of cancer patients generally improve patient outcome, there are a number of 
barriers that prevent the full realisation of these benefits. Such barriers include insufficient facilities, time constraint and poor interprofessional 
relationships. Furthermore, some studies have shown that in some cases, decisions made at MDT meetings are not implemented [18]. Blazeby and 
colleagues reported in their study that 41 of the 273 decisions made by the MDT were not implemented [18]. Having an MDT in small hospitals 
may also be particularly challenging as all the required specialists necessary for an MDT may not be available in such hospitals.  
  
  
Discussion 
 
In general, many of the published studies suggest that multidisciplinary team meeting is valuable in the management of patients with cancer. 
These studies have been carried out mostly in the United States of America and the United Kingdom. It would be worthwhile if studies could also 
be conducted in several other countries so as to identify any differences in cultural or medical practice that might have an impact on MDT.  
  
The methodology of many of the published studies appears flawed. The studies frequently used before-and-after designs, which are considered as 
weak evidence for determining causal relationships because of multiple potential confounders. New designs should be looked into in future studies 
and there should be an adjustment for any confounder in case-control studies. Randomised control trials may actually be the best tool to evaluate 
the effectiveness of the multidisciplinary team.  
  
Multidisciplinary team meetings (MDTs) form part of the daily activities in many hospitals caring for cancer patients as a form of institutionalised 
communication. The degree of organisation and the type of communication in these MDTs has a direct impact on the quality of patient care 
provided. Undoubtedly, following the Calman-Heine report, the inception of the MDT in many hospitals has resulted in better management of 
cancer patients and has resulted in improved quality of life for such patients. One resulting decision from a multidisciplinary discussion is more 
accurate and effective than the sum of all individual opinions. Also, even when individual opinions are accurate in some cases, the MDT meetings 
provide assurance on the accuracy of such decisions. In other words, the MDT provides important second opinions for patients. Furthermore, 
through active discussion and retrospective cases review in meetings, specialists gain valuable experience of how treatments can be combined to 
optimise patient outcome. Multidisciplinary team management ensures that the standard of patient care is consistent, which was a major problem 
before the inception of MDT in many hospitals. MDT meetings also provide a valuable avenue of teaching for medical students and junior doctors, 
and also improve communication between different specialists. The author of this paper has himself attended a number of MDT meetings at the 
University Hospital of Wales, Cardiff and Princess of Wales Hospital, Bridgend, and found them a valuable learning avenue.  
  
An MDT requires mature leadership to create a democratic climate that allows for open and constructive discussion. Controversies, which are 
inevitable within a team that is striving to reach decisions concerning complex situations, thus require a variety of approaches for dealing with 
them when they occur.  
  
In order to tackle barriers to MDT meetings such as time constraints, the meetings should be appropriately integrated into the work schedule of 
specialists and be given equal weighting just as ward rounds or theatre sessions. Also, it may be helpful for small or district hospitals to have 
facilities for teleconferencing so that specialists do not have to travel to the large teaching hospitals to attend these meetings. Finally, the progress 
of patients should be reviewed regularly in consequent multidisciplinary team meetings to ensure that decisions taken previously are implemented 
appropriately.  
  
With increasing emphasis  on MDT management of cancer patients, future doctors  in almost all specialties are more  likely to be  involved in 
multidisciplinary cancer care. Not only surgeons and medical oncologists would be involved in the management of cancer patients, but also general 
practitioners, pathologists, radiologists, palliative care specialists and psychiatrists. Therefore, it is essential for medical students to become familiar 
with the principles and practice of multidisciplinary teams early in their medical careers. This will promote interdisciplinary interactions that will 
facilitate effective teamwork. In fact, some studies have suggested that in the future, cancer patients may be involved in MDT meetings [19].  
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Conclusion 
 
With the increasing incidence of cancer and growing complexity of cancer care, multidisciplinary teams have the potential of improving the quality 
of life and increasing survival of cancer patients. Although there are a number of challenges to the success of the MDT, continuous commitment 
and support will ensure that MDT achieve its full potential in delivering effective and efficient cancer care. Finally, more prospective studies should 
be conducted to further evaluate the efficacy of the MDT and to highlight factors that may be militating against its success so that such factors 
could be addressed to ensure that patients receive the best possible care.  
  
  
Competing interests 
 
The author declares no competing interests.  
  
  
References 
 
1.  The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. A policy framework for commissioning cancer 
services: A report by the expert advisory group on cancer to the Chief Medical Officers of England and WalesLondon: Department of 
Health; 1995 
 
2.  Barts  and  The  London  HPB  Centre.  Multidisciplinary  team.  London:  Royal  London  Hospital.  Available: 
http://www.bartsandthelondon.nhs.uk/our-services/hpb-centre/meet-the-team/multidisciplinary-team/. Accessed: 31st May 2011 
 
3.  East  Kent  Hospitals  University  NHS  Foundation  TrustThe  Lung  Cancer  Multidisciplinary  TeamKent:  Directorate  of  Cancer,  Clinical 
Haematology and Haemophilia; 2010 
 
4.  Royal Free. Urology Multidisciplinary team (MDT). London: Royal Free Hampsted NHS Trust; 2010 
 
5.  Eastbourne District General Hospital. An Introduction to the Breast Multidisciplinary Team. East Sussex: East Sussex Hospitals NHS Trust; 
2010 
 
6.  University Hospitals Bristol NHS Foundation Trust. What is a multidisciplinary team (MDT)? Bristol: University Hospitals Bristol NHS 
Foundation  Trust.  Available:  http://www.uhbristol.nhs.uk/itsinthebag/what-you-need-to-know/multi-disciplinary-team.  Accessed  31st 
May 2011 
 
7.  Barnet  Hospital.  Role  of  the  Colorectal  Cancer  Multi-disciplinary  Team  (MDT).  Herts:  Barnet  and  Chase  Farm  Hospitals NHS  Trust. 
Available: http://www.bcf.nhs.uk/dl/12917_4412566181.pdf/as/Bowel%20Cancer%20MDT%20-%20BH.pdf. Accessed: 31st May 2011 
 
8.  South  East  Wales  Cancer  Network.  The  Multidisciplinary  Team  (MDT).  Wales:  NHS;  2010.  Available: 
http://www.wales.nhs.uk/sites3/page.cfm?orgid=362&pid=6103. Accessed: 3rd January 2011 
 
9.  Kurpad R, Kim W, Kim Rathmell W, Godley P, Whang Y, Fielding J, Smith L, Pettiford A, Schultz H, Nielsen M, Wallen EM, Pruthi RS. A 
multidisciplinary  approach  to  the  management  of  urologic  malignancies:  Does  it  influence  diagnostic  and  treatment  decisions?.Urol 
Oncol. 2009 Jul 2. This article on PubMed 
 
10.  MacDermid E, Hooton G, MacDonald M, McKay G, Grose D, Mohammed N et al. Improving patient survival with the colorectal cancer 
multi-disciplinary team. Colorectal Disease. 2008; 11(3): 291-95. This article on PubMed 
 
11.  Forrest LM, McMillan DC, McArdle CS and Dunlop DJ. An evaluation of the impact of a multidisciplinary team, in a single centre, on 
treatment  and  survival  in  patients  with  inoperable  non-small-cell  lung  cancer.  Br  J  Cancer.  2005;  93(9):  977-78.  This  article  on 
PubMed 
 
12.  Bydder S, Nowak A, Marion K, Phillips M and Atun RThe impact of case discussion at a multidisciplinary team meeting on the treatment 
and survival of patients with inoperable non-small cell lung cancer. Intern Med J. 2009; 39(12): 838-41. This article on PubMed 
 
13.  Chang JH, Vines E, Bertsch H, Fraker DL, Czerniecki BJ, Rosato EF et al. The impact of a multidisciplinary breast cancer center on 
recommendations for patient management: the University of Pennsylvania experience. Cancer. 2001 Apr 1;91(7):1231-7. This article 
on PubMed 
 
14.  Fader DJ, Wise CG, Normolle DP, Johnson TM. The multidisciplinary melanoma clinic: a cost outcomes analysis of specialty care. J Am 
Acad Dermatol. 1998; 38: 742-51. This article on PubMed 
 
15.  Gabel M, Hilton NE, Nathanson SDMultidisciplinary breast cancer clinics - Do they work?. Cancer. 1997; 79(12): 2380-4. This article on 
PubMed 
 Page number not for citation purposes  5 
16.  Acher  PL,  Young  AJ,  Etherington-Foy  R,  McCahy  PJ  and  Deane  AM.  Improving  outcomes  in  urological  cancers:  the  impact  of 
"multidisciplinary team meetings". Int J Surg. 2005; 3(2): 121-23. This article on PubMed 
 
17.  Sharma A, Sharp DM, Walker LG and Monson JR. Colorectal MDTs: the team’s perspective. Colorectal Dis. 2008; 10(1): 63-8. This 
article on PubMed 
 
18.  Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R and Donovan JL. Analysis of clinical decision-making in multi-disciplinary cancer 
teams. Annals of Oncology. 2005; 17(3): 457-60. This article on PubMed 
 
19.  Choy ET, Chiu A,  Butow P, Young J and Spillane AA pilot study to evaluate the impact of  involving breast cancer patients in the 
multidisciplinary discussion of their disease and treatment plan. Breast. 2007 Apr;16(2):178-89. This article on PubMed 
 
 
 
 